Benzinga | Feb 3, 2021 07:31AM EST

Ligand Pharmaceuticals Q4 EPS $1.62 Beats $0.99 Estimate, Sales $69.99M Beat $54.09M Estimate

Ligand Pharmaceuticals (NASDAQ:LGND) reported quarterly earnings of $1.62 per share which beat the analyst consensus estimate of $0.99 by 63.64 percent. This is a 128.17 percent increase over earnings of $0.71 per share from the same period last year. The company reported quarterly sales of $69.99 million which beat the analyst consensus estimate of $54.09 million by 29.40 percent. This is a 159.19 percent increase over sales of $27.00 million the same period last year.